• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症大样本患者真实世界中的精神病学分析。

The psychosis analysis in real-world on a cohort of large-scale patients with schizophrenia.

机构信息

Guangdong Mental Health Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Science, Guangzhou, China.

School of Computer Science, South China Normal University, Guangzhou, China.

出版信息

BMC Med Inform Decis Mak. 2020 Jul 9;20(Suppl 3):132. doi: 10.1186/s12911-020-1125-0.

DOI:10.1186/s12911-020-1125-0
PMID:32646484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7477870/
Abstract

BACKGROUND

With China experiencing unprecedented economic development and social change over the past three decades, Chinese policy makers and health care professionals have come to view mental health as an important outcome to monitor. Our study conducted an epidemiological study of psychosis in Guangdong province, with 20 million real-world follow-up records in the last decade.

METHODS

Data was collected from Guangdong mental health information platform from 2010 to 2019, which had standardized disease registration and follow-up management for nearly 600,000 patients with six categories of mental diseases and 400,000 patients with schizophrenia. We conducted clinical staging for the disease course of the patients and divided the data with various factors into different stages of disease. Quantitative analysis was utilized to investigate the high relevant indicators to the disease. The results were projected on geography map for regional distribution analysis.

RESULTS

The majority cases of mental disease incidence were between the age of 15 and 29, while the peak age for both male and female was between 20 to 24 years old. The disease course with the largest number of patients' cases was between 5 to 10 years. The therapeutic effect of patients gradually decreased with the development of disease course, while the risk increased with the disease course. The analysis of influencing factors showed that poor economic conditions incurred higher risk scores, and good medication adherence was effective in improving treatment outcomes. In addition, receiving good education contributed to the reduction of the risk of schizophrenia and the improvement of the efficiency of early treatment. Through the analysis of regional distribution of schizophrenia disease, developed economic conditions and favorable resource conditions could promote the reduction of disease risk, while in economically backward regions, it often accompanied with lower therapeutic effect and higher disease risk.

CONCLUSIONS

Certain demographic factors had a relatively prominent impact on the therapeutic effect and risk of schizophrenia, such as high-quality medication adherence. Therapeutic effect and risk were highly correlated. Backward economic conditions often associated with poor efficacy and higher risk assessment, and the developed economy and better medical resource are beneficial for the treatment of psychotic.

摘要

背景

过去三十年来,中国经历了前所未有的经济发展和社会变革,政策制定者和卫生保健专业人员开始将精神健康视为需要监测的重要结果。我们的研究对广东省的精神病进行了流行病学研究,利用过去十年的 2000 万例真实世界随访记录。

方法

数据来自 2010 年至 2019 年的广东省心理健康信息平台,该平台对六类精神疾病的近 60 万名患者和 40 万名精神分裂症患者进行了标准化疾病登记和随访管理。我们对患者的疾病病程进行了临床分期,并根据各种因素将数据分为不同的疾病阶段。采用定量分析方法调查与疾病高度相关的指标,将结果投射到地理地图上进行区域分布分析。

结果

精神疾病发病的大多数病例发生在 15 至 29 岁之间,而男性和女性的发病高峰年龄均在 20 至 24 岁之间。患者病例数量最多的疾病病程在 5 至 10 年之间。随着疾病病程的发展,患者的治疗效果逐渐下降,而风险则随着疾病病程的发展而增加。影响因素分析表明,经济条件差的患者风险评分较高,良好的药物依从性可有效改善治疗效果。此外,接受良好的教育有助于降低精神分裂症的发病风险,提高早期治疗的效果。通过对精神分裂症疾病的区域分布分析发现,经济发达条件和有利的资源条件可以降低疾病风险,而在经济落后地区,往往伴随着较低的治疗效果和较高的疾病风险。

结论

某些人口统计学因素对精神分裂症的治疗效果和风险有相对突出的影响,如高质量的药物依从性。治疗效果和风险高度相关。经济落后条件往往与疗效不佳和风险评估较高相关,发达的经济和更好的医疗资源有利于精神疾病的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/71a8df824fa0/12911_2020_1125_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/05a72cf37190/12911_2020_1125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/5c4a5e3ca1fb/12911_2020_1125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/670038e92dd3/12911_2020_1125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/286c537083b5/12911_2020_1125_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/5ec13ac27030/12911_2020_1125_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/7cede06fe1e7/12911_2020_1125_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/caebf72915f0/12911_2020_1125_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/da88d880942d/12911_2020_1125_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/7b28f06bd1a1/12911_2020_1125_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/91647f33acbe/12911_2020_1125_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/ee2e43074e28/12911_2020_1125_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/98ada9540441/12911_2020_1125_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/ee7fa3776038/12911_2020_1125_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/24e2bd6da6a4/12911_2020_1125_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/f4d9b4dfcf7d/12911_2020_1125_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/30ae83a961cc/12911_2020_1125_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/462bd19031fc/12911_2020_1125_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/8d74e6b2d8aa/12911_2020_1125_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/80c2a9fc0a56/12911_2020_1125_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/71a8df824fa0/12911_2020_1125_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/05a72cf37190/12911_2020_1125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/5c4a5e3ca1fb/12911_2020_1125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/670038e92dd3/12911_2020_1125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/286c537083b5/12911_2020_1125_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/5ec13ac27030/12911_2020_1125_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/7cede06fe1e7/12911_2020_1125_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/caebf72915f0/12911_2020_1125_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/da88d880942d/12911_2020_1125_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/7b28f06bd1a1/12911_2020_1125_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/91647f33acbe/12911_2020_1125_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/ee2e43074e28/12911_2020_1125_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/98ada9540441/12911_2020_1125_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/ee7fa3776038/12911_2020_1125_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/24e2bd6da6a4/12911_2020_1125_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/f4d9b4dfcf7d/12911_2020_1125_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/30ae83a961cc/12911_2020_1125_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/462bd19031fc/12911_2020_1125_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/8d74e6b2d8aa/12911_2020_1125_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/80c2a9fc0a56/12911_2020_1125_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/7653906/71a8df824fa0/12911_2020_1125_Fig20_HTML.jpg

相似文献

1
The psychosis analysis in real-world on a cohort of large-scale patients with schizophrenia.精神分裂症大样本患者真实世界中的精神病学分析。
BMC Med Inform Decis Mak. 2020 Jul 9;20(Suppl 3):132. doi: 10.1186/s12911-020-1125-0.
2
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.精准医疗,首次就诊:高度个性化和基于评估的青少年心理健康管理医疗模式。
Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383.
3
Duration of Untreated Psychosis in Chinese and Mauritian: Impact of Clinical Characteristics and Patients' and Families' Perspectives on Psychosis.中国和毛里求斯未治疗精神病的持续时间:临床特征以及患者和家庭对精神病的看法的影响。
PLoS One. 2016 Jun 9;11(6):e0157083. doi: 10.1371/journal.pone.0157083. eCollection 2016.
4
The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.EPPIC 首发精神病后续研究:首发住院 7 年后的长期临床和功能结局。
J Clin Psychiatry. 2010 Jun;71(6):716-28. doi: 10.4088/JCP.08m04846yel.
5
First-episode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia.首发精神病:一项比较精神病性抑郁与精神分裂症的流行病学调查。
J Affect Disord. 2008 Jan;105(1-3):117-24. doi: 10.1016/j.jad.2007.04.025. Epub 2007 Jun 14.
6
Retrospective study of first episode psychosis in the Dublin Southwest Mental Health Service: demographics, clinical profile and service evaluation of treatment.都柏林西南部心理健康服务机构首发精神病的回顾性研究:人口统计学、临床概况及治疗服务评估
Ir J Psychol Med. 2019 Dec;36(4):249-258. doi: 10.1017/ipm.2017.46. Epub 2017 Sep 12.
7
Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia: A 1-year study.未治疗精神病的时间和持续时间对中国首发精神分裂症患者认知及社会功能的影响:一项为期1年的研究。
Nord J Psychiatry. 2015 May;69(4):254-61. doi: 10.3109/08039488.2014.929738. Epub 2015 Mar 3.
8
[What support of young presenting a first psychotic episode, when schooling is being challenged?].当学业受到挑战时,对于首次出现精神病发作的年轻人有哪些支持措施?
Encephale. 2017 Dec;43(6):570-576. doi: 10.1016/j.encep.2017.10.001. Epub 2017 Nov 8.
9
The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: study protocol for a randomized controlled trial.基于正念的干预措施对认知功能和心理健康的影响:一项在智利样本中对精神分裂症和高风险精神状态进行早期干预的研究:随机对照试验的研究方案
Trials. 2017 May 25;18(1):233. doi: 10.1186/s13063-017-1967-7.
10
Patterns and predictors of trajectories for social and occupational functioning in patients presenting with first-episode non-affective psychosis: A three-year follow-up study.首发非情感性精神病患者社会和职业功能轨迹的模式和预测因素:一项为期 3 年的随访研究。
Schizophr Res. 2018 Jul;197:131-137. doi: 10.1016/j.schres.2018.01.021. Epub 2018 Feb 1.

引用本文的文献

1
Development of a medication literacy assessment scale for patients with mental disorders in recovery in China: a mixed-methods Delphi study.中国康复期精神障碍患者用药素养评估量表的研制:一项混合方法德尔菲研究
Front Psychiatry. 2025 May 27;16:1551160. doi: 10.3389/fpsyt.2025.1551160. eCollection 2025.
2
Violent behavior and the network properties of psychopathological symptoms and real-life functioning in patients with schizophrenia.精神分裂症患者的暴力行为以及精神病理症状的网络属性与现实生活功能
Front Psychiatry. 2024 Jan 11;14:1324911. doi: 10.3389/fpsyt.2023.1324911. eCollection 2023.
3
[Association Between Medication Compliance and Various Risky Behaviors in Patients With Schizophrenia].

本文引用的文献

1
International incidence of psychotic disorders, 2002-17: a systematic review and meta-analysis.国际精神病障碍发病率,2002-2017 年:系统评价和荟萃分析。
Lancet Public Health. 2019 May;4(5):e229-e244. doi: 10.1016/S2468-2667(19)30056-8.
2
Prevalence of mental disorders in China: a cross-sectional epidemiological study.中国精神障碍的患病率:一项横断面流行病学研究。
Lancet Psychiatry. 2019 Mar;6(3):211-224. doi: 10.1016/S2215-0366(18)30511-X. Epub 2019 Feb 18.
3
Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016.
[精神分裂症患者的药物依从性与各种危险行为之间的关联]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1201-1207. doi: 10.12182/20231360303.
4
Influencing factors of multiple adverse outcomes among schizophrenia patients using count regression models: a cross-sectional study.采用计数回归模型分析精神分裂症患者多项不良结局的影响因素:一项横断面研究。
BMC Psychiatry. 2022 Jul 15;22(1):472. doi: 10.1186/s12888-022-04070-3.
5
Regional years of life lost, years lived with disability, and disability-adjusted life-years for severe mental disorders in Guangdong Province, China: a real-world longitudinal study.中国广东省严重精神障碍的区域生命损失年、残疾生存年和伤残调整生命年:一项真实世界的纵向研究。
Glob Health Res Policy. 2022 Jun 20;7(1):17. doi: 10.1186/s41256-022-00253-3.
6
Disease risk analysis for schizophrenia patients by an automatic AHP framework.精神分裂症患者疾病风险的自动 AHP 框架分析。
BMC Med Inform Decis Mak. 2022 Jan 11;21(Suppl 9):375. doi: 10.1186/s12911-022-01749-1.
全球精神分裂症的流行病学和负担:来自 2016 年全球疾病负担研究的结果。
Schizophr Bull. 2018 Oct 17;44(6):1195-1203. doi: 10.1093/schbul/sby058.
4
Pragmatic Psychiatric Epidemiology-If You Can't Count It, It Won't Count.实用精神科流行病学——如果你无法计数,那就无足轻重。
JAMA Psychiatry. 2018 Feb 1;75(2):111-112. doi: 10.1001/jamapsychiatry.2017.4184.
5
Association of Environment With the Risk of Developing Psychotic Disorders in Rural Populations: Findings from the Social Epidemiology of Psychoses in East Anglia Study.农村人口中环境与患精神障碍风险的关联:东安格利亚精神病社会流行病学研究的结果
JAMA Psychiatry. 2018 Jan 1;75(1):75-83. doi: 10.1001/jamapsychiatry.2017.3582.
6
The family economic status and outcome of people with schizophrenia in Xinjin, Chengdu, China: 14-year follow-up study.中国成都新津精神分裂症患者的家庭经济状况和结局:14 年随访研究。
Int J Soc Psychiatry. 2017 May;63(3):203-211. doi: 10.1177/0020764017692840. Epub 2017 Mar 7.
7
The China Mental Health Survey: II. Design and field procedures.中国精神卫生调查:II. 设计与现场流程
Soc Psychiatry Psychiatr Epidemiol. 2016 Nov;51(11):1547-1557. doi: 10.1007/s00127-016-1269-5. Epub 2016 Nov 1.
8
The China Mental Health Survey (CMHS): I. background, aims and measures.中国精神卫生调查(CMHS):I. 背景、目标与措施
Soc Psychiatry Psychiatr Epidemiol. 2016 Nov;51(11):1559-1569. doi: 10.1007/s00127-016-1270-z. Epub 2016 Oct 31.
9
The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study.精神病早期干预服务中首发精神病的流行病学:东安格利亚精神病社会流行病学 [SEPEA] 研究的结果
Am J Psychiatry. 2017 Feb 1;174(2):143-153. doi: 10.1176/appi.ajp.2016.16010103. Epub 2016 Oct 24.
10
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.澳大利亚和新西兰皇家精神科医学院精神分裂症及相关障碍管理临床实践指南。
Aust N Z J Psychiatry. 2016 May;50(5):410-72. doi: 10.1177/0004867416641195.